Current Health's AI wearable for keeping chronically ill patients out of the hospital gets FDA clearance

A wearable device that uses artificial intelligence to remotely track and analyze multiple vital signs while worn by patients at home has been cleared by the Food and Drug Administration.

The AI-powered wearable remote patient monitoring device from Edinburgh, Scotland-based Current Health received Class II clearance from the FDA for post-acute care, marking the first time that an end-to-end, real-time, passive RPM wearable and platform has received clearance from the agency, officials from the company said.

View this post on